Steadtrust’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Steadtrust's ONC Position: Q2 2026 in Review
Steadtrust increased its BeOne Medicines (ONC) stake by 3.7% in Q2 2026, buying an estimated $14.7K and bringing the position to 1,400 shares worth $399K. The position accounts for 0.2% of the portfolio, ranked #103.
Steadtrust first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $486K in Q4 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Steadtrust held 1,400 shares of BeOne Medicines worth $399K as of Q2 2026.
- Steadtrust bought 50 BeOne Medicines shares in Q2 2026, an estimated $14.7K.
- BeOne Medicines made up 0.2% of Steadtrust's portfolio in Q2 2026, its #103 holding.
- Steadtrust first reported a position in BeOne Medicines in Q4 2025 and has held it in 3 quarters since.
- Steadtrust's BeOne Medicines position peaked at $486K in Q4 2025.
- 285 funds tracked by Wall St. Rank held BeOne Medicines as of Q2 2026.
Based on Steadtrust's 13F filing for Q2 2026, filed 9 Jul 2026.